Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV) - Drugs.com MedNews
Links shared publicly online about this topic.
- 99total visits
Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV) - Drugs.com MedNews
Aug 3, 2011 - Merck (NYSE MRK), known outside the United States and Canada as MSD, and Serum Institute of India Limited, an Indian company, announced today an a
View full resource at drugs.com
Tags: Vaccination, Pneumococcal Vaccine, Drug, Vaccine, Merck & Co.
Most Recently Shared on August 3, 2011 at 2:09 pm By:
Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conju... http://bit.ly/qrFjgU #drug
Advertisement
